Entrepreneurship programs can compare startups at different stages by using a common assessment framework while interpreting readiness, evidence, and risk relative to each company’s stage. A pre-seed startup should not be expected to demonstrate the same evidence as a later-stage company, but both can be evaluated according to whether they are addressing the risks appropriate to their current stage.

Comparing startups is difficult because entrepreneurship programs rarely work with perfectly homogeneous cohorts.

One company may still be validating a problem. Another may have a working product and early customers. Another may already have meaningful revenue, employees, and increasingly complex operations.

Applying exactly the same expectations to all three would produce misleading results.

At the same time, treating every startup as completely unique makes systematic startup progress measurement almost impossible.

The solution is not to eliminate comparison. It is to make the comparison stage-aware.

Use the Same Framework, but Different Expectations

Startups at different stages face many of the same categories of risk.

Within Juan Damia’s De-Risking Startups Framework™, startups are assessed across six interconnected dimensions: Founder, Team, Market, Product, Business Operations, and Finance.

Those dimensions remain relevant as the startup develops.

What changes is what good evidence looks like within them.

A pre-seed company may demonstrate Market progress through credible customer discovery and evidence that a meaningful problem exists. A later-stage startup may need evidence of repeatable demand, retention, market expansion, or sustainable customer acquisition.

Both are being evaluated within the Market dimension.

But the expectations are appropriate to the company’s current stage.

The framework can remain consistent while the evidence required by the framework evolves.

Stage Provides Context, Not the Entire Diagnosis

Startup stage is useful because it provides context.

It would make little sense to penalize a very early company for not having the operational infrastructure expected of a business with dozens of employees.

But stage alone does not tell us whether a startup is healthy.

Two pre-seed companies can have very different risk structures. One may have strong Founder and Team fundamentals but substantial Market uncertainty. Another may have compelling customer evidence but serious founder-alignment problems.

The same is true at later stages.

This is why startup assessment should not simply ask:

“What stage is this company?”

It should also ask:

“Given this stage, what should we reasonably expect to know, and which risks should the company be addressing?”

That distinction makes comparison much more meaningful.

Risk Changes as Startups Develop

Startup development does not mean that risk simply decreases over time.

The type and structure of risk change.

An early startup may have significant uncertainty around the problem, customer, product, founding team, and business model.

As the company validates those assumptions, some risks decrease. But growth introduces new dependencies.

Hiring creates organizational complexity. Customer growth increases operational requirements. Revenue creates expectations around repeatability. Larger teams require stronger accountability. Capital raises change financial commitments. Technology decisions become harder to reverse.

A later-stage company may therefore know much more about its business and still face substantial risk.

The relevant question is not whether it has fewer risks than a pre-seed startup.

It is whether it is managing the risks that its current condition creates.

Business Readiness Should Also Be Interpreted by Stage

The same principle applies to startup business readiness.

A pre-seed company can be appropriately ready for its stage without having the capabilities expected of a later-stage startup.

Readiness should therefore not be confused with maturity.

The question is whether the startup has the evidence, capabilities, and risk profile appropriate to what it is currently trying to accomplish.

This allows entrepreneurship programs to use structured readiness measures without automatically favoring companies that are simply further along.

Otherwise, a later-stage startup would almost always appear “better” because it has more customers, more revenue, more employees, and more operating history.

That would measure maturity more than progress.

Compare Trajectory as Well as Current Condition

One of the most useful ways to compare startups at different stages is to examine change over time.

Consider two startups.

Startup A is pre-seed and begins the program with substantial uncertainty. During the program, it validates an important customer problem, rejects an incorrect assumption, develops a stronger product hypothesis, and reduces several critical risks.

Startup B is later-stage and enters with substantially greater business readiness. During the same period, however, its underlying condition changes very little.

Which startup performed better?

There is no useful answer if the only comparison is absolute maturity.

But there is another comparison available:

How much did each startup improve relative to its own baseline?

This makes trajectory especially valuable for heterogeneous cohorts.

Programs can consider both:

Current condition + Change from baseline

The first describes where the startup is.

The second describes how it is progressing.

Compare Risk Reduction, Not Just Milestones

Stage-aware comparison also helps prevent misleading milestone comparisons.

Ten paying customers may represent extraordinary evidence for one startup and a serious concern for another.

The number itself requires context.

Programs can instead examine whether companies are systematically reducing the uncertainties and vulnerabilities most relevant to their stage.

Did the startup identify the right risks?

Did it prioritize them appropriately?

Did founders take meaningful action?

Did those actions generate credible evidence?

Did reassessment show that important risks decreased?

Did new risks emerge as the company developed?

This creates a more useful basis for comparing startup progress than simply counting identical milestones across every company.

Standardization and Personalization Can Coexist

Entrepreneurship programs sometimes assume they must choose between standardized measurement and individualized startup support.

They do not.

The assessment structure can be standardized while interpretation remains contextual.

The dimensions can be consistent. The assessment methodology can be consistent. The process for identifying and prioritizing risk can be consistent. The measurement of baseline and reassessment can be consistent.

But the expectations, priorities, and actions can reflect the individual startup.

This follows the same principle Rocketbeet applies to entrepreneurship programs more broadly:

Standardize the measurement system. Personalize the startup journey.

Why This Matters for Large Cohorts

Stage-aware measurement becomes especially valuable when universities, accelerators, incubators, and other entrepreneurship programs manage diverse portfolios.

Without a common framework, managers may struggle to understand the cohort systematically.

With overly standardized milestones, they risk comparing companies unfairly.

Rocketbeet’s Founders OS addresses this through structured assessment and stage-aware interpretation of startup risk and business readiness. Programs can maintain a consistent view across the portfolio while examining each company’s underlying risks, priorities, and trajectory.

This creates the ability to move from:

Cohort → Stage or Segment → Startup → Priority

A program manager can understand the overall portfolio without pretending that every company should look the same.

Compare Startups Without Pretending They Are the Same

There is no need to choose between comparing startups and respecting their differences.

Startups can be evaluated through a common framework while applying expectations appropriate to their stage and circumstances.

The objective is not to ask whether a pre-seed startup looks like a later-stage startup.

It is to determine whether each company is building the evidence, capabilities, and readiness it should have—and reducing the risks it should be addressing—given where it currently is.

Good startup benchmarking does not ask whether different-stage startups have achieved the same things. It asks whether each is making the progress appropriate to where it is now.